SOAN - AngioSoma, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.0004 (-4.30%)
At close: 3:36PM EDT
Stock chart is not supported by your current browser
Previous Close0.0093
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0082 - 0.0090
52 Week Range0.0082 - 0.1300
Avg. Volume1,408,648
Market Cap817,448
Beta (3Y Monthly)-4.76
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire13 days ago

    AngioSoma Announces Accomplishments of Diabetes Relief

    Houston, TX, March 06, 2019 -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company is excited about recent news of accomplishments of Diabetes Relief.

  • eQuine Holdings Discloses 8% Stake In AngioSoma (SOAN)
    PR Newswire3 months ago

    eQuine Holdings Discloses 8% Stake In AngioSoma (SOAN)

    DALLAS , Dec. 28, 2018 /PRNewswire/ -- eQuine Holdings, a Class II Multi-Family Office, has disclosed an eight percent (8%) equity stake in AngioSoma (OTC-PINK:SOAN). On December 17, 2018 AngioSoma announced ...

  • GlobeNewswire3 months ago

    AngioSoma Announces Acquisition of Diabetes Relief

    Houston, TX, Dec. 14, 2018 -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has entered into a partially binding letter of intent to acquire 100%.

  • GlobeNewswire4 months ago

    AngioSoma Creates New Partnership Opportunity

    Peripheral Artery Disease Device Manufacturer Targeted for Joint Venture HOUSTON, Nov. 13, 2018 -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research.

  • GlobeNewswire4 months ago

    AngioSoma Committed to Expanding Cosmeceutical Future

    New Industry Data and Product Roadmap Align for Optimistic Outlook HOUSTON, Nov. 08, 2018 -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and.

  • Business Wire6 months ago

    AngioSoma Announces New Ecommerce Platform Featuring Innovative Products

    The site,, features products within the Nutraceutical and Cosmeceutical industries currently with a future roadmap to expand product offerings with key partnerships and their growing Amazon storefront. AngioSoma is optimistic the new site launch paired with a new, innovative marketing plan will provide a solid foundation to continue research and development of new product lines designed to enhance lives. “The new sub-brand and website exemplifies AngioSoma’s innovative approach to the market and our unique target audience with a feature rich ecommerce site that sets the foundation for our future growth plans,” says Alex Blankenship, president of AngioSoma.

  • Business Wire6 months ago

    AngioSoma to Organize Business to Enhance Future Success

    AngioSoma (SOAN) today announced they will organize the business into three new business units to meet specific and emerging market opportunities: Pharmaceuticals, Nutraceuticals, and Cosmeceuticals. “We have made great strides in the past six months to leverage our growing market strength and operational efficiencies,” said AngioSoma president and chief executive officer, Alex Blankenship. The first new division, Pharmaceuticals, focused exclusively on delivering innovative pharma-based solutions for the rapidly-growing, multi-billion-dollar medical market, will provide industry-leading research and development to provide treatment for many serious medical problems.

  • Business Wire6 months ago

    AngioSoma Launches a New Suite of Products Formulated for Men and Women, Morning and Night

    Original StemStrength™ was designed for men only but AngioSoma is excited to reveal the new StemStrength™ will be for both Women and Men, plus it will come in an AM and PM formulation. AngioSoma is excited to continue to innovate for its customers across the spectrum of health-related products.

  • Business Wirelast year

    AngioSoma, Inc. (OTC: SOAN) Announces Launch of Website

    We are pleased to announce we have initiated our new website, to market our SomaceuticalsTM line of health supplements. Our innovative supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.